ANGO Logo

AngioDynamics, Inc. (ANGO) 

NASDAQ
Market Cap
$372.88M
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
241 of 963
Rank in Industry
14 of 49

Largest Insider Buys in Sector

ANGO Stock Price History Chart

ANGO Stock Performance

About AngioDynamics, Inc.

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

Insider Activity of AngioDynamics, Inc.

Over the last 12 months, insiders at AngioDynamics, Inc. have bought $202,847 and sold $0 worth of AngioDynamics, Inc. stock.

On average, over the past 5 years, insiders at AngioDynamics, Inc. have bought $516,566 and sold $770,544 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Clemmer James C (President and CEO) — $187,600. Nighan Warren JR (SVP Quality and Regulatory) — $10,570. Trowbridge Stephen A (EVP and CFO) — $9,962.

The last purchase of 100 shares for transaction amount of $608 was made by Nighan Warren JR (SVP Quality and Regulatory) on 2024‑10‑10.

List of Insider Buy and Sell Transactions, AngioDynamics, Inc.

2024-10-10PurchaseSVP Quality and Regulatory
100
0.0002%
$6.08$608+13.52%
2024-10-08PurchaseEVP and CFO
1,700
0.0033%
$5.86$9,962+18.11%
2024-10-07PurchasePresident and CEO
20,000
0.0399%
$6.03$120,600+13.77%
2024-10-07PurchaseSVP Quality and Regulatory
768
0.0015%
$6.09$4,677+13.77%
2024-04-08PurchasePresident and CEO
10,000
0.0254%
$6.70$67,000+2.87%
2023-01-31SaleSVP Global Operations and R&D
4,633
0.0117%
$12.95$59,997-34.41%
2022-10-12PurchaseEVP and CFO
1,083
0.0027%
$13.82$14,967-23.49%
2022-10-10PurchasePresident and CEO
10,000
0.0264%
$15.00$150,000-24.76%
2022-07-29SaleSVP Global Operations and R&D
5,000
0.0126%
$22.44$112,200-43.32%
2022-04-28SaleSVP Global Operations and R&D
3,513
0.009%
$22.44$78,832-37.25%
2022-04-12Saledirector
1,299
0.0034%
$23.26$30,215-34.97%
2022-04-11Sale
7,500
0.0197%
$23.05$172,838-31.92%
2022-01-12PurchaseEVP and CFO
2,000
0.0052%
$22.64$45,280-6.16%
2022-01-11PurchasePresident and CEO
20,000
0.0498%
$22.84$456,800-11.60%
2021-10-20SaleSVP Global Operations and R&D
6,988
0.0176%
$27.97$195,454-21.70%
2021-10-15SaleSr. VP/GM, Global VIT
24,000
0.0627%
$27.92$670,080-18.23%
2021-10-05SaleSVP/GM, Vascular Access
21,496
0.0543%
$27.15$583,616-17.96%
2021-04-14SaleSVP Global Operations and R&D
7,000
0.0182%
$23.93$167,510+6.62%
2021-01-20Saledirector
13,000
0.0335%
$18.53$240,890+35.77%
2020-08-11PurchaseEVP and CFO
2,026
0.0055%
$9.38$19,004+123.55%

Insider Historical Profitability

10.06%
Clemmer James CPresident and CEO
681582
1.6774%
$9.1880+14.85%
Trowbridge Stephen AEVP and CFO
172711
0.425%
$9.1842+31.3%
Nighan Warren JRSVP Quality and Regulatory
45877
0.1129%
$9.1820
STERN HOWARD Sdirector, 10 percent owner
1647687
4.0549%
$9.18035
Burgstahler David F
381406
0.9386%
$9.1803
Avista Capital Partners GP, LLC10 percent owner
381406
0.9386%
$9.1803
MEYERS DAVID Pdirector
336980
0.8293%
$9.18033
HOBBS EAMONN PPresident & CEO
100401
0.2471%
$9.18327+11.48%
BUCCI VINCENTdirector
86696
0.2134%
$9.1890<0.0001%
JOHNSON WESLEYdirector
79704
0.1961%
$9.1823<0.0001%
Gould Kevin Jdirector
55124
0.1357%
$9.1831+8.54%
DONNELLY HOWARD Wdirector
47600
0.1171%
$9.1831+17.81%
Centea ScottSr. VP/GM, Global VIT
46244
0.1138%
$9.1801
DEVIVO JOSEPHPresident and CEO
38000
0.0935%
$9.1840<0.0001%
ECHENBERG PAUL SDirector Emeritus
31976
0.0787%
$9.1801
Campbell Chad ThomasSVP/GM, Vascular Access
31741
0.0781%
$9.1801
Kapusta Matthew CSVP, Business Development
27005
0.0665%
$9.1820+8.01%
GOLD JEFFREYdirector
25233
0.0621%
$9.1811+6.67%
Meteny Dennis Sdirector
21950
0.054%
$9.1820+16.07%
Greiner Charles RVP - Global Franchise
20910
0.0515%
$9.1805
Richard StarkSVP, GM - Oncology
20754
0.0511%
$9.1804
Greiner MichaelEVP and CFO
20731
0.051%
$9.1801
Helsel DaveSVP Global Operations and R&D
19189
0.0472%
$9.1805
Keltjens JanPresident & CEO
15000
0.0369%
$9.1840+18.72%
LaPorte Stevedirector
8013
0.0197%
$9.1880+1.5%
Shea Paul JVP - Sales
2562
0.0063%
$9.18013
Orsatti Charles Thomasdirector
2000
0.0049%
$9.1810+20%
FLAHERTY ROBERT Edirector
1200
0.003%
$9.1810+19.04%
ROSSELL ROBERT MVP - Marketing
1000
0.0025%
$9.1817+116.9%
RECINELLA DANIELVP - Product Development
892
0.0022%
$9.1803
Stern Linda B10 percent owner
891
0.0022%
$9.18026
APPLING WILLIAM MVice-President - Research
654
0.0016%
$9.18017
Casciaro Gregory Ddirector
500
0.0012%
$9.1810+19.04%
REED JAN STERNdirector
316
0.0008%
$9.1810+2.38%
GERARDI JOSEPH GVice President
242
0.0006%
$9.18025
KUNST BRIANVP - Regulatory Affairs
0
0%
$9.1806
MAPES HAROLDVP - Operations
0
0%
$9.18012

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$27.49M11.694.68M-7.17%-$2.12M<0.01
The Vanguard Group$13.11M5.582.23M-1.57%-$209,007.24<0.0001
Systematic Financial Management LLC$11.43M4.861.95M+0.75%+$84,733.460.32
Morgan Stanley$11.02M4.681.88M-0.51%-$56,070.26<0.01
Dimensional Fund Advisors$7.96M3.381.36M-8.98%-$784,936.44<0.01
Millennium Management LLC$7.42M3.161.26M-31.17%-$3.36M0.01
Renaissance Technologies$6.68M2.841.14M+31.76%+$1.61M0.01
Paradigm Capital Management Inc Ny$6.33M2.691.08MNew+$6.33M0.31
State Street$5.98M2.541.02M+0.85%+$50,622.88<0.0001
Acadian Asset Management$5.94M2.531.01M+11.91%+$632,411.590.02
Geode Capital Management$5.34M2.27909,076+1.37%+$72,021.27<0.0001
Armistice Capital Llc$5.12M2.18872,000+9%+$422,640.000.02
Citadel Advisors LLC$5M2.13851,503-16.01%-$952,542.58<0.01
Assenagon Asset Management S.A.$4.76M2.03811,332-23.02%-$1.42M0.01
Jacobs Levy Equity Management$4.03M1.71686,040-18.55%-$917,252.110.02
Two Sigma Advisers LP$3.98M1.69678,000-1.75%-$71,027.000.01
JPMorgan Chase$3.9M1.66663,903-5.9%-$244,303.55<0.0001
Two Sigma$3.45M1.47587,098-10.41%-$400,422.020.01
D. E. Shaw & Co.$3.37M1.43574,160-5.01%-$177,808.16<0.01
Fund 1 Investments Llc$3.12M1.33531,891+7.04%+$205,449.990.51
Western Standard Llc$3.07M1.31523,393+878.54%+$2.76M4.15
ROYCE & ASSOCIATES INC$3.02M1.29514,935New+$3.02M0.03
Segall Bryant & Hamill$2.58M1.1439,241+0.97%+$24,871.190.05
AQR Capital$2.38M1.01406,295-41.48%-$1.69M<0.01
Acuitas Investments, LLC$2.37M1.01403,2800%+$01.26
Nuveen$2.21M0.94375,750-12.7%-$320,965.80<0.01
Point72 Asset Management$2.12M0.9360,442+17,063.9%+$2.1M<0.01
Northern Trust$2M0.85340,273-2.18%-$44,518.09<0.0001
Panagora$1.96M0.83333,888+52.6%+$675,549.100.01
Rice Hall James & Associates, LLC$1.94M0.82329,896-0.3%-$5,793.690.11
Charles Schwab$1.87M0.8318,378+4.68%+$83,547.72<0.0001
Marshall Wace$1.68M0.71285,957+1,437.4%+$1.57M<0.01
Arrowstreet Capital, Limited Partnership$1.43M0.61243,217+6.1%+$82,145.36<0.01
Royal Bank of Canada$1.24M0.53210,802+38.28%+$342,442.71<0.0001
Ameriprise Financial$1.21M0.51205,831-7.86%-$103,077.20<0.0001
Engineers Gate Manager Lp$1.16M0.5198,360+6.54%+$71,514.200.03
Cubist Systematic Strategies$1.16M0.49196,834-26.57%-$418,167.210.01
Kennedy Capital Management Inc$1.12M0.48190,236+425.02%+$903,991.480.02
ExodusPoint Capital Management, LP$1.11M0.47189,660-69.88%-$2.58M0.01
Mitsubishi UFJ Kokusai Asset Management$1.1M0.47187,622-7.05%-$83,541.83<0.01
Connor Clark & Lunn Investment Management Ltd$1.07M0.46182,851+34.33%+$274,281.53<0.01
Goldman Sachs$981,593.000.42167,222-14.03%-$160,162.93<0.0001
State of Wisconsin Investment Board$942,722.000.4160,600-6.9%-$69,853.00<0.01
BNY Mellon$935,265.000.4159,330-20.42%-$239,953.32<0.0001
Envestnet Asset Management Inc$931,681.000.4158,719+27.52%+$201,076.95<0.0001
Invesco$893,966.000.38152,294+138.4%+$518,972.70<0.0001
Qube Research & Technologies$845,274.000.36143,999+80.18%+$376,155.41<0.01
Shay Capital Llc$733,750.000.31125,000+66.67%+$293,500.000.11
Bank of America$720,513.000.31122,745-14.65%-$123,721.96<0.0001
Factorial Partners Llc$683,855.000.29116,500+31.64%+$164,360.000.39
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.